November 2022

Malay Mail

Beijing residents can start making appointments for an inhalable Covid booster made by CanSino Biologics, media reported on Thursday, while those in Tianjin city can now get it as the Chinese pharmaceutical firm distributes more supplies. CanSino’s vaccine, called Convidecia Air, is an aerosol version of an inactive shot and was approved as an emergency-use booster by Chinese health authorities in September.

Additive Manufacturing

Osteopore International, a Singapore- and Australia-based med-tech company, focusing on facilitating natural tissue regeneration, is primed for the global limelight after quietly developing and commercializing its novel 3D-printed bioresorbable scaffold implants that have the potential to revolutionize the way surgeons help patients to naturally regrow bones and other tissues.

AsiaOne

Indonesia’s food and drug agency said on Wednesday (Nov 9) it had suspended the licences of two more local drug companies producing syrup-type medications, as authorities investigate the deaths of nearly 200 children due to acute kidney injury. The Southeast Asian country temporarily banned sales of some syrup-based medications in October after it identified the presence in some products of ethylene glycol and diethylene glycol as possible factors for causing the illness.

CosmeticDesign Asia

More than 15% of whitening products surveyed in Malaysia were tainted with mercury, researchers from the University of Malaya have revealed.

Nature.com

Hypertension prevalence in Vietnam is high, but few people are aware of their disease status. Detection, diagnosis, and treatment are limited, so new approaches are needed to improve awareness and manage the condition, especially at the primary health care level.

Global New Light of Myanmar

The Department of Food and Drug Administration (FDA Myanmar) under the Ministry of Health has issued announcement No 18/2022.

Business World

Biotech SE, the German biotech that developed a widely used COVID-19 vaccine with Pfizer Inc PFE.N, acquired a manufacturing facility in Singapore, its first in Asia, the company said on Monday. The facility, bought from a Novartis unit, will be its first messenger ribonucleic acid, or mRNA, facility in Singapore and support its vaccines production for the Asia Pacific region, BioNTech said in a statement, without disclosing financial details.

CosmeticDesign Asia

We round up the most recent developments in the exciting Chinese beauty market, featuring news updates from EstÃe Lauder, L’Occitane, Pola Orbis and more.

CosmeticDesign Asia

In our round-up of the recent product developments in the Asia Pacific beauty and personal care market, we look into a vitamin K serum, a prebiotic hand sanitiser and more.

CosmeticDesign Asia

Sa Sa Malaysia has recovered to 77.4% of pre-pandemic levels, reflecting the positive impact of the relaxation of pandemic measures that came into effect across the country in April.